
Phase 3 OptIMMize-1 findings show sustained skin clearance, itch reduction, and quality-of-life improvements with risankizumab through 52 weeks.
It is valid to ask how serious the issue of frivolous physician malpractice claims is. Unfortunately, there is a dearth of good data on this issue.